Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19 - Archive ouverte HAL Access content directly
Journal Articles International Journal of Antimicrobial Agents Year : 2021

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19

(1) , (2) , (3) , (4) , (2)
1
2
3
4

Domains

Life Sciences [q-bio] Microbiology and Parasitology Bacteriology Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Parasitology Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Human health and pathology Infectious diseases

Isabelle COMBE  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03215689

Submitted on : Monday, May 3, 2021-2:54:56 PM

Last modification on : Friday, April 1, 2022-3:45:50 AM

Consult the full text

Dates and versions

hal-03215689 , version 1 (03-05-2021)

Identifiers

Cite

Philippe Gautret, Jean-Christophe Lagier, Stéphane Honoré, van Thuan Hoang, Didier Raoult. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106242. ⟨10.1016/j.ijantimicag.2020.106242⟩. ⟨hal-03215689⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU INCIAM
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More